NO163920C - Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever. - Google Patents

Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.

Info

Publication number
NO163920C
NO163920C NO843591A NO843591A NO163920C NO 163920 C NO163920 C NO 163920C NO 843591 A NO843591 A NO 843591A NO 843591 A NO843591 A NO 843591A NO 163920 C NO163920 C NO 163920C
Authority
NO
Norway
Prior art keywords
pivka
procedure
determining
physiological tests
antibody
Prior art date
Application number
NO843591A
Other languages
English (en)
Norwegian (no)
Other versions
NO163920B (no
NO843591L (no
Inventor
Ichiro Matsuda
Kunihiko Motohara
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO843591L publication Critical patent/NO843591L/no
Publication of NO163920B publication Critical patent/NO163920B/no
Publication of NO163920C publication Critical patent/NO163920C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO843591A 1983-09-13 1984-09-11 Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever. NO163920C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58167458A JPS6060557A (ja) 1983-09-13 1983-09-13 Ｐｉｖｋａ−２の測定方法および試薬

Publications (3)

Publication Number Publication Date
NO843591L NO843591L (no) 1985-03-14
NO163920B NO163920B (no) 1990-04-30
NO163920C true NO163920C (no) 1990-08-08

Family

ID=15850047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843591A NO163920C (no) 1983-09-13 1984-09-11 Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.

Country Status (8)

Country Link
US (1) US4780410A (de)
EP (1) EP0142634B1 (de)
JP (1) JPS6060557A (de)
KR (1) KR880001338B1 (de)
AT (1) ATE48037T1 (de)
CA (1) CA1234045A (de)
DE (1) DE3480494D1 (de)
NO (1) NO163920C (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769320A (en) * 1982-07-27 1988-09-06 New England Medical Center Hospitals, Inc. Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations
DK0500921T3 (da) * 1990-09-11 1999-11-29 Univ California Na-K-ATPase-inhiberende natriuretiske substanser
JPH0720127A (ja) * 1993-05-07 1995-01-24 Eisai Co Ltd 各種ｐｉｖｋａの測定方法および測定試薬
CA2378711A1 (en) * 1999-08-14 2001-02-22 November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin Method for indirectly determining the blood-clotting status
DE19941447C2 (de) * 1999-08-14 2002-06-27 November Ag Molekulare Medizin Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus
US6893831B1 (en) * 1999-12-14 2005-05-17 Sanko Junyaku Co., Ltd. Immunoassay of PIVKA-II
FI119203B (fi) * 2005-03-21 2008-08-29 Juha Horsti Menetelmä protrombiiniajan määrittämiseksi
US9120862B2 (en) 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
CN103620409B (zh) * 2011-05-20 2017-04-12 阿波特日本有限公司 用于减少非特异性结合的免疫检验方法和试剂
US10641768B2 (en) * 2011-07-08 2020-05-05 Abbott Japan Co. Ltd. Methods and kits for decreasing interferences from leukocytes in specific binding assays
JP6032470B2 (ja) 2012-08-09 2016-11-30 富士レビオ株式会社 Ｐｉｖｋａ−ｉｉ測定方法、測定試薬及び測定キット
JP2013152247A (ja) * 2013-04-12 2013-08-08 Abbott Japan Co Ltd 非特異的相互作用抑制剤及びその診断測定系への応用
KR102549704B1 (ko) 2015-10-07 2023-06-30 후지레비오 가부시키가이샤 Pivka-ii의 측정 방법, 및 pivka-ii 면역측정 시약 또는 키트의 제조 방법
CN106468711A (zh) * 2016-09-07 2017-03-01 北京热景生物技术股份有限公司 Dcp快速分离检测试剂盒
JPWO2021107105A1 (de) 2019-11-29 2021-06-03

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS57136165A (en) * 1981-02-18 1982-08-23 Mochida Pharmaceut Co Ltd Immunological measuring reagent
JPS57201853A (en) * 1981-06-08 1982-12-10 Toyobo Co Ltd Measuring method for human chorionic gonadotropin

Also Published As

Publication number Publication date
JPS6060557A (ja) 1985-04-08
EP0142634B1 (de) 1989-11-15
EP0142634A1 (de) 1985-05-29
NO163920B (no) 1990-04-30
ATE48037T1 (de) 1989-12-15
JPH0543357B2 (de) 1993-07-01
KR850002385A (ko) 1985-05-13
CA1234045A (en) 1988-03-15
US4780410A (en) 1988-10-25
KR880001338B1 (ko) 1988-07-25
NO843591L (no) 1985-03-14
DE3480494D1 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
ATE40602T1 (de) Immunchemisches messverfahren.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
DE3486030D1 (de) Monoklonale antikoerper, spezifisch von in vivo von fibrinogen abgeleiteten derivatstuecken.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
DE3571504D1 (en) Method for immunologically measuring antigens, antibodies or haptens, the use of this method for measuring lipoproteins and alpha-fetoprotein and test kits for the performance of this method
BE857121A (fr) Antigene et anticorps pour un essai de determination immunologique de la thymopoietine, et leur application
ATE27366T1 (de) Immunologisches latex-agglutinationsverfahren.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
ES522186A0 (es) Metodo de ensayo de anticuerpos.
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
ATE73463T1 (de) Monoklonale antikoerper.
ES552074A0 (es) Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
DK134487D0 (da) Monoklonalt antistof med affinitet for humant interleukin-2
YU164090A (sh) Postopek za dokazovanje analitov
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
SE8101404L (sv) Reagens och sett for bestemning av aldolas av human-muskeltyp
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
NO834535L (no) Fremgangsmaate for affinitetsrensing under anvendelse av monoklonale antistoffer.
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.

Legal Events

Date Code Title Description
MK1K Patent expired